| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/01/2007 | CN1329032C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/01/2007 | CN101010313A Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder |
| 08/01/2007 | CN101010296A Piperazine derivatives of alkyhydroxy indole |
| 08/01/2007 | CN101010081A Mitochondria activators |
| 08/01/2007 | CN101008023A Technology for extracting dihydrogalanthamine from lycoris radiata genus plant |
| 08/01/2007 | CN101008012A Novel human-derived neurotrophic factor BDNF expression structure and its expression |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007791A Amino acid diphenyl compound |
| 08/01/2007 | CN101007166A Use of derivatives of erythropoietin carbamylated in preparation of medicine |
| 08/01/2007 | CN101007162A Medicine bag containing traditional Chinese medicine for physiotherapy |
| 08/01/2007 | CN101007153A Drug of gastrodia elata for caring brain |
| 08/01/2007 | CN101007144A Traditional Chinese medicine for treating lumbago and leg pain induced by spine originated retrograde affection and preparation method |
| 08/01/2007 | CN101007141A Oral liquid for disease-treatment and health-care |
| 08/01/2007 | CN101007121A A prescription of Chinese medicinal wine or capsule for treating sciatica |
| 08/01/2007 | CN101007120A External applied medicine for treating facial paralysis |
| 08/01/2007 | CN101007086A Use of 'Si Ni San' for treating insomnia or improving sleep quality |
| 08/01/2007 | CN101007068A A medicinal composition for treating epilepsy and its preparation method |
| 08/01/2007 | CN101007055A Preparation method of pollen of eucommia ulmoides soft capsules containing alpha-linolenic acid |
| 08/01/2007 | CN101007035A Application of notoginseng glycol saponins and its preparation for treating memory deterioration, preventing and controlling Alzheimer disease |
| 08/01/2007 | CN101007010A Application of thiophosphorylation amino and its methyl in preparation of drug for relieving chronic pain |
| 08/01/2007 | CN101007005A Preparation of sublingual administered nalmefene hydrochloride |
| 08/01/2007 | CN101007002A Huperzine A pellets preparation and its preparation method |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101007000A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006999A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006985A Pharmacological composition |
| 08/01/2007 | CN101006853A Processing method of natural bamboo juice soy sauce |
| 08/01/2007 | CN101006807A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006806A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006805A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 07/31/2007 | US7250531 Process for the synthesis and crystalline form of agomelatine |
| 07/31/2007 | US7250525 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250430 Administering N-benzoyl- derivatives, e.g., N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt, to treat metastatic soft tissue sarcoma, non-small cell lung cancer, melanoma, ovarian cancer, breast cancer, leukemia, lymphoma, renal cancer, prostate cancer, and multiple myeloma |
| 07/31/2007 | US7250429 Aminomethyl-substituted thiazolobenzimidazole compounds |
| 07/31/2007 | US7250422 Preventing and inhibiting morphine tolerance caused by repeated administration of morphine, while not affecting the analgesic effects of morphine upon a single administration |
| 07/31/2007 | US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders |
| 07/31/2007 | US7250411 Benzothiazine and benzothiadiazine compounds |
| 07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250394 Blocking glutamate function at an ionotropic glutamate receptor. e.g., N-methyl-D-aspartate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptor and the kainate receptor; brain disorders; spinal chord |
| 07/31/2007 | US7250294 Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | CA2305612C Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 07/31/2007 | CA2223397C Novel nor-pregnanes for inducing hypothalamic effects |
| 07/31/2007 | CA2186260C Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 07/31/2007 | CA2184802C Process for manufacture of imidazo benzodiazepine derivatives |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084914A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists |
| 07/26/2007 | WO2007084841A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 07/26/2007 | WO2007084557A2 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | WO2007084535A2 Neuronal nicotinic receptor ligands and their use |
| 07/26/2007 | WO2007084424A2 Treatment of substance abuse |
| 07/26/2007 | WO2007083985A1 Synergistic pharmaceutical composition of diclofenac and lysine clonixinate |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083634A1 Therapeutic agent for traumatic neuropathy and/or movement disorder |
| 07/26/2007 | WO2007083631A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 07/26/2007 | WO2007083239A1 Pyridine derivatives as sodium channel modulators |
| 07/26/2007 | WO2007083228A1 Overall therapeutic approach in the treatment of neurodegenerative diseases |
| 07/26/2007 | WO2007083146A2 The treatment of cognitive and psychotic disorders |
| 07/26/2007 | WO2007083098A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | WO2007082973A1 Use of a polypeptide that comprises the c-terminal domain of the heavy chain of tetanus toxin in the treatment of parkinsonism |
| 07/26/2007 | WO2007082935A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts |
| 07/26/2007 | WO2007082914A2 Method of diagnosis and method of treatment |
| 07/26/2007 | WO2007082909A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | WO2007082806A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer’s disease via gaba receptors |
| 07/26/2007 | WO2007082731A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 07/26/2007 | WO2007082561A2 Method for the treatment of tinnitus |
| 07/26/2007 | WO2007082546A1 Use of tofisopam as a pde10a inhibitor |
| 07/26/2007 | WO2007061360A3 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 07/26/2007 | WO2007057756A3 Isocystene derivatives for the treatment of pain |
| 07/26/2007 | WO2007056124A3 Compounds for modulating trpv3 function |
| 07/26/2007 | WO2007051836A3 Compositions for treating dermatological and neurological disorders |
| 07/26/2007 | WO2007048026A3 Cgrp peptide antagonists and conjugates |
| 07/26/2007 | WO2007044441A3 Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 07/26/2007 | WO2007025798A3 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 07/26/2007 | WO2006119170A3 Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease |
| 07/26/2007 | WO2006065706A9 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173522 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6- tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 07/26/2007 | US20070173518 Crystal of ticagrelor; G-protein coupled receptor antagonist, used for treating arterial thrombotic complications |
| 07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
| 07/26/2007 | US20070173505 A2a adenosine receptor antagonists |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173491 Substituted lactams as inhibitors of Abeta protein production |
| 07/26/2007 | US20070173457 Tau-conotoxin peptides |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173453 Methods of preventing or treating brain ischemia or brain injury |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |